0.012674 0.000000 0.000000 0.000000 0.012674 0.000000 0.000000 0.000000 0.012674 0.00000 0.00000 0.00000 Gursky, O. Badger, J. Li, Y. Caspar, D.L.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 24 90.00 90.00 90.00 78.900 78.900 78.900 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H4 Cl2 98.959 1,2-DICHLOROETHANE ETHYLENE DICHLORIDE non-polymer C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking Na 1 22.990 SODIUM ION non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biophys.J. BIOJAU 0030 0006-3495 63 1210 1220 1477273 Conformational changes in cubic insulin crystals in the pH range 7-11. 1992 US Biophys.J. BIOJAU 0030 0006-3495 61 604 Monovalent Cation Binding in Cubic Insulin Crystals 1992 US Biophys.J. BIOJAU 0030 0006-3495 61 816 Flexibility in Crystalline Insulins 1992 DK Acta Crystallogr.,Sect.B ASBSDK 0622 0108-7681 47 127 Structure of the Pig Insulin Dimer in the Cubic Crystal 1991 US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 88 622 Water Structure in Cubic Insulin Crystals 1991 UK J.Mol.Biol. JMOBAK 0070 0022-2836 125 387 Zinc-Free Cubic Pig Insulin: Crystallization and Structure Determination 1978 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 2339.645 INSULIN A CHAIN (PH 11) 1 man polymer 3403.927 INSULIN B CHAIN (PH 11) 1 man polymer 22.990 SODIUM ION 1 syn non-polymer 98.959 1,2-DICHLOROETHANE 1 syn non-polymer 18.015 water 60 nat water no no GIVEQCCASVCSLYQLENYCN GIVEQCCASVCSLYQLENYCN A polypeptide(L) no no FVNQHLCGSHLVEALYLVCGERGFFYTPKA FVNQHLCGSHLVEALYLVCGERGFFYTPKA B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n cattle Bos sample 9913 Bos taurus cattle Bos sample 9913 Bos taurus 3.56 65.47 pdbx_database_status struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1993-01-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site 0.1M SODIUM SALT SOLUTION AT PH 7 0.1M SODIUM SALT SOLUTION AT PH 9 0.1M SODIUM SALT SOLUTION AT PH 10 SHEET THERE IS A SHEET COMPRISING TWO ANTIPARALLEL STRANDS PHE B 24 - TYR B 26 FROM TWO DIMER-FORMING INSULIN MOLECULES. Y BNL 1992-10-30 REL REL NA SODIUM ION DCE 1,2-DICHLOROETHANE HOH water THE 1,2-DICHLOROETHANE IS BOUND IS CIS CONFORMATION IN A SYMMETRIC POSITION ACROSS THE CRYSTALLOGRAPHIC TWO-FOLD AXIS BETWEEN THE TWO INSULIN DIMER-FORMING MOLECULES. NA 88 3 NA NA 88 A DCE 200 4 DCE DCE 200 B HOH 1 5 HOH HOH 89 A HOH 10 5 HOH HOH 90 A HOH 12 5 HOH HOH 91 A HOH 13 5 HOH HOH 92 A HOH 15 5 HOH HOH 93 A HOH 18 5 HOH HOH 94 A HOH 21 5 HOH HOH 95 A HOH 23 5 HOH HOH 96 A HOH 24 5 HOH HOH 97 A HOH 26 5 HOH HOH 98 A HOH 30 5 HOH HOH 99 A HOH 33 5 HOH HOH 100 A HOH 35 5 HOH HOH 101 A HOH 39 5 HOH HOH 102 A HOH 41 5 HOH HOH 103 A HOH 42 5 HOH HOH 104 A HOH 43 5 HOH HOH 105 A HOH 44 5 HOH HOH 106 A HOH 45 5 HOH HOH 107 A HOH 47 5 HOH HOH 108 A HOH 53 5 HOH HOH 109 A HOH 54 5 HOH HOH 110 A HOH 56 5 HOH HOH 111 A HOH 59 5 HOH HOH 112 A HOH 60 5 HOH HOH 113 A HOH 2 5 HOH HOH 201 B HOH 3 5 HOH HOH 202 B HOH 4 5 HOH HOH 203 B HOH 5 5 HOH HOH 204 B HOH 6 5 HOH HOH 205 B HOH 7 5 HOH HOH 206 B HOH 8 5 HOH HOH 207 B HOH 9 5 HOH HOH 208 B HOH 11 5 HOH HOH 209 B HOH 14 5 HOH HOH 210 B HOH 16 5 HOH HOH 211 B HOH 17 5 HOH HOH 212 B HOH 19 5 HOH HOH 213 B HOH 20 5 HOH HOH 214 B HOH 22 5 HOH HOH 215 B HOH 25 5 HOH HOH 216 B HOH 27 5 HOH HOH 217 B HOH 28 5 HOH HOH 218 B HOH 29 5 HOH HOH 219 B HOH 31 5 HOH HOH 220 B HOH 32 5 HOH HOH 221 B HOH 34 5 HOH HOH 222 B HOH 36 5 HOH HOH 223 B HOH 37 5 HOH HOH 224 B HOH 38 5 HOH HOH 225 B HOH 40 5 HOH HOH 226 B HOH 46 5 HOH HOH 227 B HOH 48 5 HOH HOH 228 B HOH 49 5 HOH HOH 229 B HOH 50 5 HOH HOH 230 B HOH 51 5 HOH HOH 231 B HOH 52 5 HOH HOH 232 B HOH 55 5 HOH HOH 233 B HOH 57 5 HOH HOH 234 B HOH 58 5 HOH HOH 235 B GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A ALA 8 n 8 ALA 8 A SER 9 n 9 SER 9 A VAL 10 n 10 VAL 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B PRO 28 n 28 PRO 28 B LYS 29 n 29 LYS 29 B ALA 30 n 30 ALA 30 B author_and_software_defined_assembly PISA 2 dimeric software_defined_assembly PISA 4 tetrameric software_defined_assembly PISA 4 tetrameric software_defined_assembly PISA 4 tetrameric 1640 -20 3270 4900 -72 5350 3170 -66 7080 4240 -54 5570 A HOH 94 E O HOH 1_555 A NA 88 C NA NA 1_555 A GLN 5 A O GLN 5 1_555 96.7 A HOH 94 E O HOH 1_555 A NA 88 C NA NA 1_555 A VAL 10 A O VAL 10 1_555 110.9 A GLN 5 A O GLN 5 1_555 A NA 88 C NA NA 1_555 A VAL 10 A O VAL 10 1_555 83.3 A HOH 94 E O HOH 1_555 A NA 88 C NA NA 1_555 A HOH 96 E O HOH 1_555 83.4 A GLN 5 A O GLN 5 1_555 A NA 88 C NA NA 1_555 A HOH 96 E O HOH 1_555 165.2 A VAL 10 A O VAL 10 1_555 A NA 88 C NA NA 1_555 A HOH 96 E O HOH 1_555 82.8 A HOH 94 E O HOH 1_555 A NA 88 C NA NA 1_555 A SER 9 A OG SER 9 1_555 119.6 A GLN 5 A O GLN 5 1_555 A NA 88 C NA NA 1_555 A SER 9 A OG SER 9 1_555 77.6 A VAL 10 A O VAL 10 1_555 A NA 88 C NA NA 1_555 A SER 9 A OG SER 9 1_555 127.5 A HOH 96 E O HOH 1_555 A NA 88 C NA NA 1_555 A SER 9 A OG SER 9 1_555 115.3 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 16_565 x,-y+1,-z+1/2 crystal symmetry operation 0.0000000000 78.9000000000 39.4500000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 15_556 -x+1/2,y,-z+1 crystal symmetry operation 39.4500000000 0.0000000000 78.9000000000 0.0000000000 0.0000000000 1.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 5_555 z,x,y crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 20_556 -z+1/2,x,-y+1 crystal symmetry operation 39.4500000000 0.0000000000 78.9000000000 1 B HOH 230 F HOH 1 B CG LYS 29 B CG LYS 29 1 Y 1 B CD LYS 29 B CD LYS 29 1 Y 1 B CE LYS 29 B CE LYS 29 1 Y 1 B NZ LYS 29 B NZ LYS 29 1 Y 1 -9.40 1.20 123.30 113.90 A A A OE1 CD OE2 GLU GLU GLU 4 4 4 N 1 4.29 0.60 121.00 125.29 A A A CB CG CD2 TYR TYR TYR 14 14 14 A A A N 1 -4.32 0.60 121.00 116.68 A A A CB CG CD1 TYR TYR TYR 14 14 14 A A A N 1 22.73 1.80 110.60 133.33 A A A N CA CB ASN ASN ASN 18 18 18 B N 1 7.27 1.10 114.20 121.47 A A A CA CB SG CYS CYS CYS 20 20 20 N 1 -13.20 2.00 118.30 105.10 B B B CG CD OE2 GLU GLU GLU 13 13 13 N 1 25.22 2.00 110.40 135.62 B B B CB CA C GLU GLU GLU 21 21 21 B N 1 -13.23 1.80 110.60 97.37 B B B N CA CB GLU GLU GLU 21 21 21 B N 1 32.80 2.20 113.40 146.20 B B B CA CB CG GLU GLU GLU 21 21 21 A A N 1 -21.63 2.20 113.40 91.77 B B B CA CB CG GLU GLU GLU 21 21 21 B B N 1 14.83 1.80 110.60 125.43 B B B N CA CB ARG ARG ARG 22 22 22 B N 1 -6.64 0.50 120.30 113.66 B B B NE CZ NH1 ARG ARG ARG 22 22 22 B B B N 1 -17.54 2.00 110.40 92.86 B B B CB CA C PHE PHE PHE 25 25 25 B N 1 B LYS 29 -64.12 93.70 IN 1BPH AND 1CPH, THE SIDE CHAIN OF GLU A 4 CAN ADOPT TWO ALTERNATIVE POSITIONS WHICH OVERLAP. THEIR RELATIVE WEIGHT AND THE ATOMIC POSITIONS OF THE SECOND CONFORMER ARE NOT ACCURATELY DETERMINED. IN 1APH, 1BPH, AND 1DPH, THE SIDE CHAIN OF GLU B 21 IS DISORDERED. IT HAS BEEN MODELED AS SUPERPOSITION OF TWO CONFORMATIONS BUT ATOMIC POSITIONS FOR THESE CONFORMATIONS ARE PROBABLY NOT VERY ACCURATE. THE SIDE CHAIN OF LYS B 29 IS POORLY DEFINED IN THE ELECTRON DENSITY MAPS. IN 1APH AND 1CPH, IT IS INCLUDED WITH PARTIAL OCCUPANCY. IN 1BPH AND 1DPH, ITS COORDINATES HAVE BEEN OMITTED FROM THE ENTRY. THE MAIN AND SIDE CHAIN OF ALA B 30 (C-TERMINAL RESIDUE OF CHAIN B) CAN ADOPT TWO SEPARATE CONFORMATIONS AND IS DISORDERED IN EACH OF THESE CONFORMATIONS, WHICH LIMITED THE ACCURACY OF DETERMINATION OF ATOMIC POSITIONS FOR THE CONFORMERS OF ALA B 30. IN 1APH AND 1CPH, SINGLE ALTERNATIVE CONFORMERS ARE PREDOMINANT BUT, DUE TO DISORDER, THEY ARE ASSIGNED PARTIAL OCCUPANCIES. IN 1BPH AND 1DPH, BOTH ALTERNATIVE CONFORMERS ARE INCLUDED IN THE ENTRY. 0.19 1.9 1 1.9 60 504 5 0 439 0.018 refinement PROLSQ INSULIN (CUBIC) IN 0.1M SODIUM SALT SOLUTION AT PH11 CONFORMATIONAL CHANGES IN CUBIC INSULIN CRYSTALS IN THE PH RANGE 7-11 1 N N 2 N N 3 N N 4 N N 5 N N 5 N N A GLY 1 A GLY 1 HELX_P A VAL 10 A VAL 10 1 A1 10 A SER 12 A SER 12 HELX_P NOT IDEAL A GLU 17 A GLU 17 5 A2 6 B SER 9 B SER 9 HELX_P B GLY 20 B GLY 20 1 B1 12 disulf 1.954 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 1.951 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 1.970 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 metalc 2.318 A NA 88 C NA NA 1_555 A HOH 94 E O HOH 1_555 metalc 2.391 A NA 88 C NA NA 1_555 A GLN 5 A O GLN 5 1_555 metalc 2.330 A NA 88 C NA NA 1_555 A VAL 10 A O VAL 10 1_555 metalc 2.340 A NA 88 C NA NA 1_555 A HOH 96 E O HOH 1_555 metalc 2.914 A SER 9 A OG SER 9 1_555 A NA 88 C NA NA 1_555 HORMONE HORMONE INS_BOVIN UNP 1 85 P01317 INS_BOVIN UNP 2 25 P01317 85 105 1DPH 1 21 P01317 A 1 1 21 25 54 1DPH 1 30 P01317 B 2 1 30 BINDING SITE FOR RESIDUE NA A 88 Software 7 BINDING SITE FOR RESIDUE DCE B 200 Software 3 A GLN 5 A GLN 5 7 1_555 A SER 9 A SER 9 7 1_555 A VAL 10 A VAL 10 7 1_555 A HOH 94 E HOH 7 15_556 A HOH 94 E HOH 7 1_555 A HOH 96 E HOH 7 1_555 A HOH 96 E HOH 7 15_556 B SER 9 B SER 9 3 1_555 B VAL 12 B VAL 12 3 16_565 B GLU 13 B GLU 13 3 16_565 199 I 21 3